ESSA Pharma Inc
EPIX0.211USD
+0.001+0.62%
收盘 09/19, 16:00（美东）报价延迟15分钟
9.37M总市值
亏损市盈率 TTM
关于 ESSA Pharma Inc 公司
ESSA Pharma Inc. 是一家加拿大临床阶段制药公司。该公司专注于开发治疗前列腺癌患者的专有疗法。其主要候选药物 Masofaniten（原名 EPI-7386）是一种口服小分子，可抑制雄激素受体 (AR) 的 N 端结构域。Masofaniten 正在开发中，用于与抗雄激素疗法联合治疗早期前列腺癌患者。该公司正在完成 Masofaniten 作为转移性去势抵抗性前列腺癌 (mCRPC) 患者的单一疗法治疗的临床开发。
公司简介
公司代码EPIX
公司名称ESSA Pharma Inc
上市日期Feb 22, 2021
CEODr. David Ross Parkinson, M.D.
员工数量35
证券类型Ordinary Share
年结日Feb 22
公司地址999 West Broadway, Suite 720
城市VANCOUVER
上市交易所NASDAQ Capital Market Consolidated
国家Canada
邮编V5Z 1K5
电话17783310962
网址https://www.essapharma.com/
公司代码EPIX
上市日期Feb 22, 2021
CEODr. David Ross Parkinson, M.D.
公司高管
名称
名称/职务
职务
持股
持股变动
Dr. Richard M. Glickman, LL.D.
Dr. Richard M. Glickman, LL.D.
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
51.70K
--
Mr. David Sidney Wood, CPA
Mr. David Sidney Wood, CPA
Chief Financial Officer
Chief Financial Officer
33.34K
-0.74%
Mr. Scott Requadt
Mr. Scott Requadt
Independent Director
Independent Director
30.00K
--
Mr. Peter Virsik
Mr. Peter Virsik
Chief Operating Officer, Executive Vice President
Chief Operating Officer, Executive Vice President
7.78K
--
Dr. Alessandra Cesano, M.D., Ph.D.
Dr. Alessandra Cesano, M.D., Ph.D.
Executive Vice President, Chief Medical Officer
Executive Vice President, Chief Medical Officer
5.12K
--
Ms. Marella Thorell
Ms. Marella Thorell
Independent Director
Independent Director
2.88K
--
Mr. Franklin M. Berger
Mr. Franklin M. Berger
Independent Director
Independent Director
--
--
Mr. Sanford (Sandy) Zweifach, CPA
Mr. Sanford (Sandy) Zweifach, CPA
Independent Director
Independent Director
--
--
Dr. David Ross Parkinson, M.D.
Dr. David Ross Parkinson, M.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Mr. Alex Martin
Mr. Alex Martin
Independent Director
Independent Director
--
--
名称
名称/职务
职务
持股
持股变动
Dr. Richard M. Glickman, LL.D.
Dr. Richard M. Glickman, LL.D.
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
51.70K
--
Mr. David Sidney Wood, CPA
Mr. David Sidney Wood, CPA
Chief Financial Officer
Chief Financial Officer
33.34K
-0.74%
Mr. Scott Requadt
Mr. Scott Requadt
Independent Director
Independent Director
30.00K
--
Mr. Peter Virsik
Mr. Peter Virsik
Chief Operating Officer, Executive Vice President
Chief Operating Officer, Executive Vice President
7.78K
--
Dr. Alessandra Cesano, M.D., Ph.D.
Dr. Alessandra Cesano, M.D., Ph.D.
Executive Vice President, Chief Medical Officer
Executive Vice President, Chief Medical Officer
5.12K
--
Ms. Marella Thorell
Ms. Marella Thorell
Independent Director
Independent Director
2.88K
--
收入明细
暂无数据
暂无数据
业务
地区
暂无数据
股东统计
更新时间: 9月19日 周五
更新时间: 9月19日 周五
持股股东
股东类型
持股股东
持股股东
占比
BVF Partners L.P.
24.66%
Soleus Capital Management, L.P.
9.22%
Tang Capital Management, LLC
9.09%
BML Capital Management LLC
8.92%
Morgan Stanley & Co. LLC
8.82%
其他
39.28%
持股股东
持股股东
占比
BVF Partners L.P.
24.66%
Soleus Capital Management, L.P.
9.22%
Tang Capital Management, LLC
9.09%
BML Capital Management LLC
8.92%
Morgan Stanley & Co. LLC
8.82%
其他
39.28%
股东类型
持股股东
占比
Hedge Fund
50.42%
Investment Advisor
11.72%
Research Firm
11.40%
Corporation
3.54%
Individual Investor
2.08%
Venture Capital
0.09%
Investment Advisor/Hedge Fund
0.08%
其他
20.68%
机构持股
更新时间: 7月1日 周二
更新时间: 7月1日 周二
报告期
机构数
持股数
持股占比
持股变动
2025Q2
91
32.28M
72.72%
-18.24M
2025Q1
96
33.48M
75.44%
-17.56M
2024Q4
101
34.20M
77.05%
-15.63M
2024Q3
97
36.44M
82.10%
-7.65M
2024Q2
110
36.54M
82.36%
-10.99M
2024Q1
138
36.33M
81.91%
-11.35M
2023Q4
143
35.77M
81.03%
-12.57M
2023Q3
161
36.59M
82.99%
-18.42M
2023Q2
177
36.37M
82.51%
-21.24M
2023Q1
185
36.21M
82.14%
-19.98M
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
BVF Partners L.P.
8.75M
19.71%
--
--
Apr 09, 2025
Soleus Capital Management, L.P.
2.26M
5.1%
--
--
Apr 23, 2025
Tang Capital Management, LLC
4.30M
9.69%
--
--
Mar 31, 2025
BML Capital Management LLC
4.22M
9.51%
--
--
Apr 24, 2025
Morgan Stanley & Co. LLC
4.20M
9.46%
+10.76K
+0.26%
Mar 31, 2025
Opaleye Management Inc.
2.21M
4.98%
--
--
Mar 31, 2025
Pfizer Inc
1.68M
3.77%
--
--
Mar 31, 2025
Berger (Franklin Milan)
784.40K
1.77%
--
--
Jan 08, 2025
BofA Global Research (US)
698.27K
1.57%
-114.04K
-14.04%
Mar 31, 2025
Aldebaran Capital, LLC
569.29K
1.28%
+171.77K
+43.21%
Mar 31, 2025
查看更多
持股ETF
更新时间: 9月6日 周六
更新时间: 9月6日 周六
机构名称
占比
Avantis US Small Cap Equity ETF
0.01%
Avantis US Small Cap Equity ETF
占比0.01%
分红派息
近5年累计派现
0.00
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
类型
比率
暂无数据
公告日期
类型
比率
暂无数据
